CYP2B6 and malaria: Two novel PCR diagnostic assays were designed to detect and monitor these mechanisms as well as assessing the fitness cost of P450-mediated metabolic resistance in the major African malaria vector An. funestus (Weedall et al., 2019; Mugenzi et al., 2019).